Related Experiment Video
Updated: Oct 30, 2025

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
Published on: April 16, 2018
Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects
Marek Samec1, Alena Liskova1, Lenka Koklesova1
1Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 03601 Martin, Slovakia.
Abstract:
Metabolic reprogramming characterized by alterations in nutrient uptake and critical molecular pathways associated with cancer cell metabolism represents a fundamental process of malignant transformation. Melatonin (N-acetyl-5-methoxytryptamine) is a hormone secreted by the pineal gland. Melatonin primarily regulates circadian rhythms but also exerts anti-inflammatory, anti-depressant, antioxidant and anti-tumor activities. Concerning cancer metabolism, melatonin displays significant anticancer effects via the regulation of key components of aerobic glycolysis, gluconeogenesis, the pentose phosphate pathway (PPP) and lipid metabolism. Melatonin treatment affects glucose transporter (GLUT) expression, glucose-6-phosphate dehydrogenase (G6PDH) activity, lactate production and other metabolic contributors. Moreover, melatonin modulates critical players in cancer development, such as HIF-1 and p53. Taken together, melatonin has notable anti-cancer effects at malignancy initiation, progression and metastasing. Further investigations of melatonin impacts relevant for cancer metabolism are expected to create innovative approaches supportive for the effective prevention and targeted therapy of cancers.
Insights
Melatonin, a natural hormone, demonstrates significant anticancer effects by regulating key cancer metabolism pathways. Further research into melatonin
Area of Science:
- Oncology
- Metabolic pathways
- Hormone research
Background:
- Metabolic reprogramming is crucial for cancer development.
- Melatonin (N-acetyl-5-methoxytryptamine) is a hormone with known anti-tumor properties.
- Melatonin influences circadian rhythms and possesses antioxidant and anti-inflammatory effects.
Purpose of the Study:
- To investigate the role of melatonin in regulating cancer metabolism.
- To explore melatonin's impact on key metabolic pathways in cancer cells.
- To assess melatonin's potential as an anti-cancer therapeutic agent.
Main Methods:
- Analysis of melatonin's effects on aerobic glycolysis, gluconeogenesis, and the pentose phosphate pathway (PPP).
- Evaluation of melatonin's influence on glucose transporter (GLUT) expression and glucose-6-phosphate dehydrogenase (G6PDH) activity.
- Examination of melatonin's modulation of cancer-related factors like HIF-1 and p53.
Main Results:
- Melatonin significantly impacts key components of cancer cell metabolism.
- Melatonin treatment alters glucose metabolism, including GLUT expression and G6PDH activity.
- Melatonin effectively modulates critical cancer development players such as HIF-1 and p53.
Conclusions:
- Melatonin exhibits notable anti-cancer effects across malignancy initiation, progression, and metastasis.
- Melatonin's regulation of cancer metabolism offers potential for innovative cancer prevention and therapy.
- Further research on melatonin's metabolic impacts is crucial for developing targeted cancer treatments.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
10:39Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Inhibition of Cdk Activity